Go here to read the rest: Adverum Biotechnologies to Participate in the 2025 RBC Capital Markets Ophthalmology Virtual Conference
Go here to read the rest: Adverum Biotechnologies to Participate in the 2025 RBC Capital Markets Ophthalmology Virtual Conference
Read more: Ascendis Submits U.S. NDA for TransCon CNP (Navepegritide) for the Treatment of Children with Achondroplasia
Visit link: Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings
View post: Aruna’s Co-Founder and Chief Scientific Officer, Dr. Steven Stice, Inducted into the 2025 Class of the American Institute for Medical and Biological...
Read more: Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
Go here to see the original: Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update
Original post: Revolution Medicines to Participate in April 2025 Investor Conferences
See the article here: Connect Biopharma Announces Publication of Positive Data from Global Phase 2 Trial of Rademikibart in Patients with Moderate-to-Severe Uncontrolled...
More here: Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights
See more here: Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates
Recent Comments